ScholarWorks@Gyeongsang National University

Browsing by Park, YongAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 12 of 12

SCIESCOPUS
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

Kim, Seok Jin; Yoon, Dok Hyun; Jaccard, Arnaud; Chng, Wee Joo; Lim, Soon Thye; Hong, Huangming; Park, Yong; Chang, Kian Meng; Maeda, Yoshinobu; Ishida, Fumihiro, et al.

ArticleIssue Date2016CitationLANCET ONCOLOGY, v.17, no.3, pp 389 - 400PublisherELSEVIER SCIENCE INC
SCIESCOPUS
A Single-Arm, Open-Label, Multicenter Study to Assess Molecular Response of P1101 Therapy in Patients with Polycythemia Vera and Elevated Hematocrit: Results from 12-Month Core Studyopen access

Lee, Sung-Eun; Yoon, Sung-Soo; Yang, Deok-Hwan; Lee, Gyeong Won; Yoon, Seug Yun; Sohn, Sang Kyun; Shin, Ho-Jin; Bae, Sung Hwa; Choi, Chul Won; Choi, Eun-Ji, et al.

ArticleIssue Date2023CitationBlood, v.142PublisherAmerican Society of Hematology
SCIESCOPUS
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantationopen access

Kim, Seok Jin; Jo, Jae-Cheol; Yoon, Dok Hyun; Yang, Deok-Hwan; Yoon, Sang Eun; Lee, Gyeong-Won; Kong, Jee Hyun; Park, Yong; Kang, Ka-Won; Lee, Ho-Sup, et al.

ArticleIssue Date2023CitationFrontiers in Oncology, v.13PublisherFrontiers Media S.A.
SCISCIESCOPUS
Current Treatment Patterns and Outcomes in Patients with Peripheral T-Cell Lymphoma: Updated Results of the Nationwide, Multi-Center Prospective Registry Study (CISL 1404)open access

Cho, Hyungwoo; Yoon, Dok Hyun; Shin, Dong-Yeop; Yoon, Sung-Soo; Kim, Seok Jin; Do, Young Rok; Lee, Gyeong-Won; Jae-Yong, Kwak; Park, Yong; Kim, Min Kyoung, et al.

ArticleIssue Date2019CitationBlood, v.134PublisherAmerican Society of Hematology
SCIESCOPUS
Distinct Factors Influence on Complete Hematological Response Maintenance in Polycythemia Vera Patients Treated with Alfa-2b: From a Phase 2 in South Korea

Lee, Sung-Eun; Yoon, Sung-Soo; Yang, Deok-Hwan; Lee, Gyeong Won; Yoon, Seug Yun; Sohn, Sang Kyun; Shin, Ho-Jin; Bae, Sung Hwa; Choi, Chul Won; Choi, Yunsuk, et al.

ArticleIssue Date2024CitationBlood, v.144, pp 6673 - 6674PublisherAmerican Society of Hematology
SCIESCOPUS
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study

Yoon, Seug Yun; Yoon, Sung-Soo; Yang, Deok-Hwan; Lee, Gyeong-Won; Sohn, Sang Kyun; Shin, Ho-Jin; Bae, Sung Hwa; Choi, Chul Won; Choi, Eun-Ji; Cheong, June-Won, et al.

ArticleIssue Date2025CitationInternational Journal of Cancer, v.157, no.3, pp 526 - 533PublisherJohn Wiley & Sons Inc.
SCIESCOPUS
Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphomaopen access

Song, Ga-Young; Yoon, Dok Hyun; Suh, Cheolwon; Moon, Joon Ho; Baek, Dong Won; Kim, Jin Seok; Lee, Gyeong-Won; Yi, Jun Ho; Park, Yong; Jung, Ki Sun, et al.

ArticleIssue Date2021CitationBone Marrow Transplantation, v.56, no.5, pp 1205 - 1208PublisherNature Publishing Group
SCISCIESCOPUS
Open-Labeled, Multicenter Phase II Study of Bortezomib for Maintenance Therapy in Patients with High Risk Diffuse Large B Cell Lymphoma (DLBCL): Borma Trial from Consortium for Improving Survival of Lymphoma (CISL)open access

Jo, Jae-Cheol; Lee, Ho Sup; Suh, Cheolwon; Kang, Hye Jin; Kim, Won Seog; Eom, HyeonSeok; Kim, Inho; Shin, Ho-Jin; Park, Yong; Lee, Won Sik, et al.

ArticleIssue Date2019CitationBlood, v.134PublisherAmerican Society of Hematology
SCIESCOPUS
Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma

Shin, Junghoon; Lee, Ji Yun; Lee, Gyeong-Won; Kim, Won Seog; Park, Yong; Do, Young Rok; Kim, Dae Sik; Kim, Ki Hwan; Choi, Yoon Seok; Byun, Ja Min, et al.

ArticleIssue Date2023CitationBritish Journal of Haematology, v.202, no.6, pp e54 - e57PublisherBlackwell Publishing Inc.
SCOPUSESCIKCI
Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trialopen access

Seo, Jeongkuk; Kim, Won Seog; Kim, Jin Seok; Kim, Seok Jin; Lee, Jae Hoon; Hong, Jun Shik; Lee, Gyeong-Won; Oh, Sung Yong; Lee, Ji-Hyun; Yoon, Dok Hyun, et al.

ArticleIssue Date2017CitationBLOOD RESEARCH, v.52, no.3, pp 200 - 206PublisherKOREAN SOC HEMATOLOGY
SCIESCOPUS
Predicting Molecular Response through Half Reduction of Neutrophil-to-Lymphocyte Ratio (NLR) in Polycythemia Vera Treatment with Ropeginterferon

Yoon, Seug Yun; Won, Jong-Ho; Lee, Sung-Eun; Yoon, Sung-Soo; Yang, Deok-Hwan; Lee, Gyeong Won; Sohn, Sang Kyun; Shin, Ho-Jin; Bae, Sung Hwa; Choi, Chul Won, et al.

ArticleIssue Date2024CitationBLOOD, v.144, pp 3170 - 3171PublisherELSEVIER
SCIESCOPUS
Refining Symptom Response Criteria in Polycythemia Vera Patients Treated with Ropeginterferon Alfa-2b

Lee, Sung-Eun; Yoon, Sung-Soo; Yang, Deok-Hwan; Lee, Gyeong Won; Yoon, Seug Yun; Sohn, Sang Kyun; Shin, Ho-Jin; Bae, Sung Hwa; Choi, Chul Won; Choi, Eun-Ji, et al.

ArticleIssue Date2024CitationBLOOD, v.144, pp 6642 - 6643PublisherELSEVIER
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어